Topamax and Sinus congestion - a phase IV clinical study of FDA data

Summary:

Sinus congestion is reported as a side effect among people who take Topamax (topiramate), especially for people who are female, 40-49 old, also take Cymbalta, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Sinus congestion when taking Topamax. It is created by eHealthMe based on reports of 54,158 people who have side effects when taking Topamax from the FDA, and is updated regularly.

What is Topamax?

Topamax has active ingredients of topiramate. It is often used in migraine. eHealthMe is studying from 58,955 Topamax users. Check the latest studies of Topamax.

What is Sinus congestion?

Sinus congestion (blockage of sinus) is found to be associated with 1,004 drugs and 955 conditions by eHealthMe. Check the latest studies of Sinus congestion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 21, 2026

54,158 people reported to have side effects when taking Topamax.
Among them, 53 people (0.1%) have Sinus congestion.

Among these 53 people:

What is the gender of people who have Sinus congestion when taking Topamax? *

female: 90 %
male: 10 %

What is the age of people who have Sinus congestion when taking Topamax? *

What are other drugs people take besides Topamax? *

What are other side effects people have besides Sinus congestion? *

Fatigue (feeling of tiredness): 16 people, 30.19%
Nausea (feeling of having an urge to vomit): 14 people, 26.42%
Joint Pain: 14 people, 26.42%
Headache (pain in head): 14 people, 26.42%
Malaise (a feeling of general discomfort or uneasiness): 13 people, 24.53%
Nasopharyngitis (inflammation of the nasopharynx): 12 people, 22.64%
Pain: 11 people, 20.75%
Rashes (redness): 11 people, 20.75%
Fever: 11 people, 20.75%
Muscle Spasms (muscle contraction): 10 people, 18.87%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 11.32%
Pain: 6 people, 11.32%
Immunodeficiency Common Variable: 6 people, 11.32%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 9.43%
Depression: 5 people, 9.43%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 9.43%
Muscle Spasms (muscle contraction): 3 people, 5.66%
Hypersensitivity: 3 people, 5.66%
Asthma: 3 people, 5.66%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 5.66%

* Approximation only. Some reports may have incomplete information.

Do you take Topamax and have Sinus congestion?

- Check whether Sinus congestion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Topamax:

Topamax (58,955 reports)

Sinus congestion treatments and more:

Sinus congestion (21,241 reports)

Browse all side effects of Topamax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinus congestion:

Sinus congestion (1,004 drugs)

Browse all the conditions that are associated with Sinus congestion:

Sinus congestion (955 conditions)

Related publications that referenced our studies

Baloch M, Siddiqui MA, "Topiramate induced sudden loss of vision", JPMA, 2012 Oct .
Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .
Baloch M, Siddiqui MA, "Topiramate induced sudden loss of vision", JPMA, 2012 Oct .
Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on topiramate (the active ingredients of Topamax) and Topamax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.